HALOZYME THERAPEUTICS, INC.
Biopharmaceutical firm licensing technology to convert IV drugs to subcutaneous forms.
HALO | US
Overview
Corporate Details
- ISIN(s):
- US40637H1095
- LEI:
- Country:
- United States of America
- Address:
- 12390 EL CAMINO REAL, 92130 SAN DIEGO
- Website:
- https://www.halozyme.com/
Description
Halozyme Therapeutics, Inc. is a biopharmaceutical company focused on its proprietary ENHANZE® drug delivery technology. This platform is based on a recombinant human hyaluronidase enzyme (rHuPH20) that facilitates the subcutaneous delivery of injected drugs and fluids. The technology enables the conversion of intravenous therapies into subcutaneous formulations, which can reduce administration time and improve the patient experience. Halozyme licenses its ENHANZE® technology to pharmaceutical and biotechnology partners, allowing them to co-formulate their proprietary therapies for use across various therapeutic areas, with a significant focus on oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HALOZYME THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
